FDA Approves Multiple Sclerosis Stem Cell Trial

A groundbreaking study using stem cells to treat multiple sclerosis (MS) has been approved by the Food and Drug Administration. If successful, scientists believe it may one day lead to a cure for the autoimmune system disease.

Researchers at the Tisch MS Research Center of New York say that approval of early clinical Phase I trials by the FDA comes after more than a decade of research.

Read More